How to Calculate Your Clinical Cost Per GLP-1 Visit (NP vs. MD, Sync vs. Async)

Most GLP-1 telehealth operators know their medication cost. Few have a clean number for their clinical cost per visit.

That gap matters. Medication is often the biggest line item, but clinical cost is the one operators can actually engineer. The right provider mix, the right visit structure, and the right state coverage model can cut clinical cost per visit by 40 to 60 percent compared to a default physician-sync setup.

This post breaks down how to build the number from scratch.

The Four Variables in Your Clinical Cost Stack

Every GLP-1 clinical visit has four cost inputs:

1. Clinician type (NP vs. physician)
2. Visit type (synchronous vs. asynchronous)
3. State licensing overhead (where are your patients located?)
4. Supervision cost (are you operating in restricted NP states?)

Each one is controllable. Together they determine your per-visit margin.

Variable 1: Clinician Type

NPs cost less per session than physicians. That is the starting point.

For GLP-1 telehealth at volume, NP rates on a per-session basis typically run $25 to $40 for initial and follow-up visits. Physician rates for the same visits run $40 to $55 at volume, and higher for lower-volume engagements.

The clinical case for NPs in GLP-1 telehealth is solid. GLP-1 weight management falls squarely within NP scope of practice in full practice authority states. A 2025 AANP study showed NP-led care delivers equivalent outcomes to physician-led care for chronic condition management at an average cost saving of $2,626 per diabetic patient compared to physician-only models.

The catch is state law. NPs can prescribe independently in roughly 28 states that have full practice authority as of mid-2026. In the remaining states, they need physician supervision. That cost gets calculated separately (see Variable 4 below).

Rule of thumb: If you are operating in full practice authority states and your volume supports it, default to NPs. Use physicians in restricted states or for complex cases.

Variable 2: Visit Type

This is where operators most commonly leave money on the table.

A synchronous visit (live video or phone) requires a clinician to block time for a real-time call. It costs more. An asynchronous visit (questionnaire-based review) allows a clinician to review and respond on their own schedule. It costs less per encounter and allows higher clinician throughput.

For GLP-1 specifically, the visit cadence breaks down like this:

Initial visit: Sync required. Most states and standard clinical protocols require a live consultation before the first GLP-1 prescription. Some states, including Texas, require a live visit before delegation from a physician to an NP as well. This is a non-negotiable sync encounter.

Follow-up refill at 60 to 90 days: Async viable. The standard GLP-1 refill cadence is every 60 to 90 days. These follow-ups can be handled asynchronously in most states, meaning the patient completes a brief questionnaire, the clinician reviews it, and the prescription is renewed. This is where operators cut significant cost.

Escalation encounters: Sync when clinically indicated. Side effects, dose adjustments, and atypical responses warrant live visits. Build these into your protocol as exception-based rather than default.

Cost impact of async vs. sync: Sync visits on a per-session basis run $25 to $55 depending on provider type and platform. Async encounters for refills can be structured at $10 to $20 per case at volume, depending on how your staffing is arranged, because one clinician can process far more async cases per hour than sync calls.

On a 90-day patient cycle with one sync initial visit and one async refill, a GLP-1 operator running NPs in full practice authority states is looking at a clinical cost in the range of $40 to $60 per patient per cycle. A physician-only sync setup for the same cycle runs $90 to $110.

Variable 3: State Licensing Overhead

Telehealth follows the patient's location. If a patient is in Texas, the clinician treating that patient needs a Texas license, regardless of where the clinician is physically located.

This has a direct cost implication. Multi-state licensing takes time and carries fees. The Interstate Medical Licensure Compact (IMLC) covers 42 states as of 2026, including Florida, Texas, and Pennsylvania, which significantly reduces the friction for physicians expanding state coverage. California and New York are not in the IMLC, meaning any clinician treating patients in those two large-volume states needs separate state licensure with timelines of four to six months.

For NPs, the Nurse Licensure Compact (NLC) covered 43 states as of early 2025, allowing RNs and licensed practical nurses (LPNs) to practice across compact states on a single multistate license. NPs under the compact benefit similarly for states that have adopted the APRN compact provisions.

What this means operationally: When mapping your target patient geographies, weight your initial launch toward states that are both high-volume and IMLC or NLC compact members. This minimizes licensing bottlenecks and upfront credentialing cost. California is a major GLP-1 market and non-compact, so factor in a four-to-six-month credentialing runway if you plan to serve it.

Credentialing costs per provider typically run $500 to $1,500 in state fees across a multi-state expansion. The operational time, roughly 40 to 60 hours of administrative work per provider across 10 to 15 states, is the larger cost for early-stage operators without a dedicated credentialing team.

Variable 4: Supervision Cost in Restricted States

This is the cost most operators underestimate, and the one that silently destroys GLP-1 margins in certain geographies.

In states that require physician supervision or collaboration for NPs, NPs cannot prescribe independently. They need a collaborating physician on contract. That physician does not need to see every patient, but must be available for oversight, typically including chart reviews, protocol sign-off, and reachability for clinical questions.

What does a collaborating physician cost? In states like Texas and Florida, where ratio limits restrict how many NPs a single physician can supervise and where geographic proximity requirements apply, collaborating physician fees run $1,000 to $3,000 per month per supervising arrangement. In states with looser ratio requirements, fees are lower.

If a collaborating physician covering a single NP costs $1,500 per month and that NP handles 100 GLP-1 patients per month, supervision overhead is $15 per patient per month. At 50 patients, it is $30. At 200 patients, it drops to $7.50. Supervision cost is fixed overhead that amortizes with scale.

The important 2026 update: The CMS 2026 Physician Fee Schedule, effective January 1, 2026, permanently allows virtual direct supervision. A supervising physician no longer needs to be physically present. Real-time audio-visual communication qualifies as direct supervision for services without 010 or 090 global surgery indicators. This removes the geographic proximity constraint for federal compliance purposes, though state-level collaboration rules remain separate and must be checked individually.

States where supervision cost is a meaningful budget line as of mid-2026:

Texas requires indefinite physician collaboration for NPs regardless of experience. It is one of the most operationally complex states for NP-led telehealth.

Florida requires 3,000 hours of supervised practice before NPs can register for autonomous APRN status, meaning most NPs still need a collaborating physician.

Alabama requires formal collaborative practice agreements with ratio limits and prescribing restrictions.

Georgia requires ongoing collaboration with no path to full independence.

New York had temporarily eliminated written collaborative agreements for experienced NPs since 2022, but that provision was set to sunset on July 1, 2026. At the time of writing, the status of Bill S2360, which would make NP independence permanent, has not been confirmed. Operators with significant New York patient volume should verify current status.

California, as noted above, began accepting applications for the 104 NP certification in January 2026 under AB 890, which allows fully independent practice for NPs who have completed 4,600 hours of supervised transition to practice. Most NPs in California are still in the transition period, meaning collaboration costs apply for the time being.

Putting It Together: Sample Cost Models

Model A: NP-led, async refills, full practice authority states

Initial sync visit: $30 (NP rate)90-day async refill: $12 (NP async rate)Supervision overhead: $0 (full practice authority)State licensing: Amortized, negligible at scale

Total clinical cost per patient per 90-day cycle: approximately $42

Model B: NP-led, async refills, restricted state with supervision

Initial sync visit: $30 (NP rate)90-day async refill: $12 (NP async rate)Supervision overhead per patient: $15 (based on $1,500/month, 100 patients)

Total clinical cost per patient per 90-day cycle: approximately $57

Model C: Physician-only, sync visits

Initial sync visit: $50 (MD rate)90-day sync refill: $50 (MD sync rate)Supervision overhead: $0

Total clinical cost per patient per 90-day cycle: approximately $100

The spread between Model A and Model C is roughly $58 per patient per cycle. On 1,000 active patients, that is $58,000 in additional clinical cost every 90 days, or approximately $232,000 annually, for operators who have not optimized their clinical model.

What This Means for Platform Design

The operators who will win on margin in compressed GLP-1 telehealth are the ones who build their visit cadence around async-by-default refills, staff NPs in full practice authority states as the primary clinician type, use physicians selectively for initial sync visits in restricted states and for clinical escalations, and treat supervision cost as a fixed overhead that needs to scale against patient volume before they enter a new state.

None of this requires a bundled platform. It requires a physician and NP network that works your intake, your protocols, and your visit cadence directly.

DirectShifts staffs physician and NP networks for GLP-1 telehealth operators across all 50 states. NP rates start at $25 per session. Supervision coverage is available in all restricted states. Operators bring their own tech and pharmacy. Schedule a call to see how the network is structured.

Frequently Asked Questions

What is the average clinical cost per GLP-1 visit in 2026?

‍It depends on provider type and visit structure. NP-led synchronous visits at volume run $25 to $40 per session. Physician-led synchronous visits run $40 to $55. Asynchronous NP refill encounters can run $10 to $20 per case at volume. The total clinical cost per 90-day patient cycle ranges from approximately $42 for an optimized NP-async model in a full practice authority state to $100 or more for a physician-only synchronous model.

Can a nurse practitioner prescribe GLP-1 medications without a supervising physician?

‍In full practice authority states, yes. NPs can prescribe independently in approximately 28 states as of mid-2026, including most of the Northeast, Midwest, and Pacific Northwest. In restricted states such as Texas, Florida, Georgia, and Alabama, NPs require a collaborating or supervising physician. The specific requirements, including chart review frequency, ratio limits, and geographic proximity rules, vary by state.

How much does a collaborating physician cost for NP supervision in a GLP-1 telehealth practice?

‍In high-restriction states like Texas and Florida, collaborating physician fees run $1,000 to $3,000 per month depending on the number of NPs covered, ratio limits, and the specific oversight requirements. At 100 patients per NP per month, this adds $10 to $30 per patient to clinical overhead. The cost amortizes as patient volume scales.

What is the difference between a synchronous and asynchronous GLP-1 visit, and when is each required?

‍A synchronous visit is a live real-time consultation between clinician and patient via video or phone. An asynchronous visit is a questionnaire-based encounter where the clinician reviews submitted health information and responds without a live call. Most protocols require a synchronous initial visit before the first GLP-1 prescription. Follow-up refill visits at 60 to 90 days can typically be structured as asynchronous encounters, which reduces per-encounter clinician cost significantly.

Do telehealth GLP-1 operators need a licensed clinician in every state?

‍Yes. Telehealth prescribing follows the state where the patient is located. Any clinician treating a patient in a given state must hold an active license in that state. The Interstate Medical Licensure Compact (IMLC) covers 42 states as of 2026 and simplifies multi-state licensing for physicians. California and New York are not in the IMLC and require separate state licensure with timelines of four to six months.

How did the CMS 2026 Physician Fee Schedule affect supervision requirements for telehealth?

‍The CMS 2026 Physician Fee Schedule, effective January 1, 2026, permanently allows virtual direct supervision. Supervising physicians no longer need to be physically present. Real-time two-way audio and video communication qualifies as direct supervision for most services. This removes geographic proximity barriers at the federal level. However, state-level collaboration and supervision rules remain separate and must be verified state by state, as they are not superseded by the federal change.